Literature DB >> 15476579

Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.

Michelle L Frost1, Ignac Fogelman, Glen M Blake, Paul K Marsden, Gary Cook.   

Abstract

UNLABELLED: Regional bone metabolism measured using 18F-fluoride PET was assessed in 72 postmenopausal women classified as normal, osteopenic, or osteoporotic. Lower values of regional bone formation activity at the lumbar spine were seen in osteoporotic women, whereas global markers of bone formation were significantly increased.
INTRODUCTION: Evaluations of global bone remodeling have revealed that increased bone turnover is a feature of patients with osteoporosis. The noninvasive functional imaging technique of 18F-fluoride positron emission tomography (PET) allows the direct quantitative assessment of bone metabolism at specific sites in the skeleton, including the clinically important site of the lumbar spine.
MATERIALS AND METHODS: The aim of this study was to compare regional skeletal kinetics in 72 postmenopausal women (mean age, 61 years) classified as normal, osteopenic, or osteoporotic according to their BMD T score at the lumbar spine. Each woman had a dynamic PET scan of the lumbar spine after injection of 90 MBq 18F-fluoride ion and measurements of biochemical markers of bone formation and resorption. The arterial plasma input function was derived using aorta arterial activity from the PET image. Time-activity curves were obtained by placing regions of interest over the lumbar vertebrae. A three-compartmental model was used to calculate bone blood flow (K1) and the net plasma clearance of tracer to bone mineral (Ki), reflecting regional osteoblastic activity (ml/minutes/ml). Rate constants k2, k3, and k4, which describe transport between plasma, the extracellular fluid (ECF) compartment, and the bone mineral compartment, were also measured.
RESULTS: The net uptake of fluoride to the bone mineral compartment (Ki) was significantly lower in the osteoporotic group compared with both the osteopenic and normal groups, with a mean difference of 0.005 ml/minutes/ml (16.7%). The fraction of the tracer in the extravascular tissue space that underwent specific binding to bone mineral (k3/k2 + k3) was also significantly reduced in the women classified as osteoporotic. In contrast, levels of bone-specific alkaline phosphatase (BSALP) were significantly higher in the osteoporotic group compared with the normal and osteopenic groups by 35% and 27%, respectively. A significant negative correlation (r = -0.41) was observed between levels of BSALP and the fraction of the tracer that underwent specific binding to bone mineral.
CONCLUSION: Lower values of Ki, a measurement of regional bone formation activity, were seen in women classified as osteoporotic, whereas levels of BSALP, a measure of global bone formation, were significantly increased. These findings are suggestive of increased global skeletal bone turnover in women with postmenopausal osteoporosis but with relatively reduced regional bone formation at the predominantly trabecular site of the lumbar spine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476579     DOI: 10.1359/JBMR.040818

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  20 in total

1.  Can PET-CT imaging and radiokinetic analyses provide useful clinical information on atypical femoral shaft fracture in osteoporotic patients?

Authors:  C Haile Chesnut; Charles H Chesnut
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

Authors:  M L Frost; M Siddique; G M Blake; A E Moore; P K Marsden; P J Schleyer; R Eastell; I Fogelman
Journal:  Osteoporos Int       Date:  2011-10-08       Impact factor: 4.507

3.  Age-related differences in the activity of arterial mineral deposition and regional bone metabolism: a 18F-sodium fluoride positron emission tomography study.

Authors:  T Derlin; T Janssen; J Salamon; S Veldhoen; J D Busch; G Schön; J Herrmann; F O Henes; P Bannas; G Adam
Journal:  Osteoporos Int       Date:  2014-08-16       Impact factor: 4.507

Review 4.  Quantitative imaging methods in osteoporosis.

Authors:  Ling Oei; Fjorda Koromani; Fernando Rivadeneira; M Carola Zillikens; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2016-12

5.  Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma.

Authors:  Christos Sachpekidis; Jens Hillengass; Hartmut Goldschmidt; Hoda Anwar; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

Review 6.  Imaging technologies for assessment of skeletal health in men.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2013-03       Impact factor: 5.096

7.  Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

Authors:  Robert K Doot; Mark Muzi; Lanell M Peterson; Erin K Schubert; Julie R Gralow; Jennifer M Specht; David A Mankoff
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

Review 8.  Imaging of inflammation and calcification in aortic stenosis.

Authors:  Marc R Dweck; Nikhil V Joshi; James H F Rudd; David E Newby
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

9.  Use of dual-energy computed tomography to measure skeletal-wide marrow composition and cancellous bone mineral density.

Authors:  Luke Arentsen; Karen E Hansen; Masashi Yagi; Yutaka Takahashi; Ryan Shanley; Angela McArthur; Patrick Bolan; Taiki Magome; Douglas Yee; Jerry Froelich; Susanta K Hui
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

10.  Bone biomarkers in koalas: validation of assays and preliminary analyses.

Authors:  Chien-Jung Chen; Stephen T Anderson; Natasha Steiger; Allan McKinnon; Joerg Henning; Rachel Allavena
Journal:  J Vet Diagn Invest       Date:  2020-09-11       Impact factor: 1.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.